IP16-18: Beyond Glycemic Control: Concurrent GLP-1 Receptor Agonist Use Is Associated with Reduced Urinary Adverse Events Following OnabotulinumtoxinA Treatment in Non-Diabetic Adults with Overactive Bladder

IP16-18: Beyond Glycemic Control: Concurrent GLP-1 Receptor Agonist Use Is Associated with Reduced Urinary Adverse Events Following OnabotulinumtoxinA Treatment in Non-Diabetic Adults with Overactive Bladder

Friday, May 15, 2026 1:00 PM to 3:00 PM · 1 hr. 59 min. (America/New_York)

146C

Abstract

Speakers

Sessions

IP16: Urodynamics/Lower Urinary Tract Dysfunction/Female Pelvic Medicine: Overactive Bladder

Friday, May 15, 2026 1:00 PM to 3:00 PM

Nirit Rosenblum · NYU

E. Ann Gormley · Professor of Surgery, Geisel School of Medicine, Dartmouth

Elisabeth Sebesta · Vanderbilt University Medical Center

Registered attendees

Elia Abou Chawareb

Elia Abou Chawareb

Research SpecialistUniversity of California, Irvine

Log in

See all the content and easy-to-use features by logging in or registering!